AltaRex Licenses U.S. Issued Patents

AltaRex Corp. has obtained an exclusive worldwide license for a family of four U.S issued patents and foreign counterparts from the Alberta Research Council, Inc. (ARC) in Edmonton, Alberta.

These additions to the Company’s intellectual property portfolio provide AltaRex with a strong foundation for developing novel treatments in the area of autoimmune/inflammatory disease, such as multiple sclerosis, Crohn’s disease, and allergy/asthma.

The Company’s current proprietary technology applies to a number of disease areas (cancer, infectious disease and autoimmune/inflammatory disease), with current clinical development focused on cancer.

“We believe that we have a broad technology platform, and anticipate generating near term return from our antibodies to treat cancer.


We are prudently extending our intellectual property now, with a future focus on promising and synergistic therapeutic areas,” commented Richard E. Bagley, President and CEO of AltaRex Corp.

The family of U.S. issued patents obtained by AltaRex from the ARC includes three method patents titled ‘Anti Inflammatory Tolerogenic and Immunoinhibiting Properties of Carbohydrate Binding Peptides’ and one composition patent titled ‘Lectin Derived Carbohydrate Binding Peptides’. These patents are relevant to the Company’s established proprietary expertise in the use of binding agents, specifically antibodies, to alter patients’ immune system responses in a therapeutically beneficial manner.

The Alberta Research Council develops and commercialises technologies to give customers a competitive advantage.

The corporation performs applied research and development on a contract or fee basis, and co-ventures with others to develop new technologies, deriving a return on investment from the commercialisation of new products and processes.

ARC also conducts applied research projects for the public good and to support provincial science and technology needs and strategies.

AltaRex Corp. is primarily focused on the research, development and commercialisation of antigen-targeted antibody-based cancer therapies, utilizing monoclonal antibodies as immunotherapeutic agents for the treatment of certain late-stage cancers.

Purchase Dragon Pharma On-line

Cypionat 250 - Cheap Price

Administration: Injection
Primary Component: Testosterone Cypionate
Manufacturer: Dragon Pharmaceuticals
Amount: 20 x 10 mL vial (250 mg/mL)
Price: 20 x $30.00

NPP 150 - Bulk Price

Administration: Injection
Basic Ingredient: Nandrolone Phenylpropionate
Produced by: Dragon Pharmaceutical
Package: 10 x 10 mL vial (150 mg/mL)
Price: 10 x $30.00

Deca 300 - Bulk Price

Administration: Injection
Base Chemical Name: Nandrolone Decanoate
Made by: Dragon Pharma LLC
Amount: 10 x 10 mL vial (300 mg/mL)
Price: 10 x $45.00

Masteron 100

Injectable Anabolic Steroid
Primary Chemical Name: Drostanolone Di-Propionate
Produced by: Dragon Pharmaceutical
Package: 1 X 10 ml (100 mg/ml)

TriTren 150 - Bulk Price

Administration: Injection
Prime Substance: Tri Trenbolone
Produced by: Dragon Pharma Labs
Unit: 10 x 10 mL vial (150 mg/mL)
Price: 10 x $72.00

Turanabol - Cheap Price

Administration: Oral
Basic Component: Chlorodehydromethyltestosterone
Produced by: Dragon Pharma Labs
Unit: 20 x 100 tabs (10 mg/pill)
Price: 20 x $60.00

Cut Mix 150 - Discount Price

Administration: Injection
Primary Constituent: Testosterone Propionate, Drostanolone Propionate, Trenbolone Acetate
Produced by: Dragon Pharma Labs
Unit: 30 x 10 mL vial (150 mg/mL)
Price: 30 x $36.00

Cut Long 300

Injectable Steroid for Muscle Growth
Mix of: Drostanolone Enanthate,
Testosterone Enanthate, Trenbolone Enanthate
Made by: Dragon Pharma LLC
10 mL Sterile Multi-dose Vial (300 mg/mL)

Suspension 100

Injectable Steroid for Muscle Growth
Main Substance: Testosterone Suspension
Producer: Dragon Pharmaceutical
10 mL Sterile Multi-dose Vial (100 mg/mL)

1-Test Cyp 200

Basic Substance: Dihydroboldenone Cypionate
Manufacturer: Dragon Pharma
Pack: 10 mL vial (200 mg/mL)

Parabolan 100

Primary Substance: Trenbolone Hexahydrobenzylcarbonate
Manufacturer: Dragon Pharma LLC
Pack: 10 x 10 mL vial (100 mg/mL)

Enantat 250

Main Substance: Testosterone Enanthate
Manufacturer: Dragon Pharmaceuticals
Package: 10 mL vial (250 mg/mL)